Sanderson RD - Search Results

1

SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis.

Ritchie JP, Ramani VC, Ren Y, Naggi A, Torri G, Casu B, Penco S, Pisano C, Carminati P, Tortoreto M, Zunino F, Vlodavsky I, Sanderson RD, Yang Y. Ritchie JP, et al. Among authors: sanderson rd. Clin Cancer Res. 2011 Mar 15;17(6):1382-93. doi: 10.1158/1078-0432.CCR-10-2476. Epub 2011 Jan 21. Clin Cancer Res. 2011. PMID: 21257720 Free PMC article.

2

Soluble syndecan-1 promotes growth of myeloma tumors in vivo.

Yang Y, Yaccoby S, Liu W, Langford JK, Pumphrey CY, Theus A, Epstein J, Sanderson RD. Yang Y, et al. Among authors: sanderson rd. Blood. 2002 Jul 15;100(2):610-7. doi: 10.1182/blood.v100.2.610. Blood. 2002. PMID: 12091355 Free article.

3

Neoglycans, carbodiimide-modified glycosaminoglycans: a new class of anticancer agents that inhibit cancer cell proliferation and induce apoptosis.

Pumphrey CY, Theus AM, Li S, Parrish RS, Sanderson RD. Pumphrey CY, et al. Among authors: sanderson rd. Cancer Res. 2002 Jul 1;62(13):3722-8. Cancer Res. 2002. PMID: 12097281

4

Heparan sulfate regulates targeting of syndecan-1 to a functional domain on the cell surface.

Yang Y, Børset M, Langford JK, Sanderson RD. Yang Y, et al. Among authors: sanderson rd. J Biol Chem. 2003 Apr 11;278(15):12888-93. doi: 10.1074/jbc.M209440200. Epub 2003 Feb 3. J Biol Chem. 2003. PMID: 12566461 Free article.

5

High heparanase activity in multiple myeloma is associated with elevated microvessel density.

Kelly T, Miao HQ, Yang Y, Navarro E, Kussie P, Huang Y, MacLeod V, Casciano J, Joseph L, Zhan F, Zangari M, Barlogie B, Shaughnessy J, Sanderson RD. Kelly T, et al. Among authors: sanderson rd. Cancer Res. 2003 Dec 15;63(24):8749-56. Cancer Res. 2003. PMID: 14695190

6

Heparanase promotes the spontaneous metastasis of myeloma cells to bone.

Yang Y, Macleod V, Bendre M, Huang Y, Theus AM, Miao HQ, Kussie P, Yaccoby S, Epstein J, Suva LJ, Kelly T, Sanderson RD. Yang Y, et al. Among authors: sanderson rd. Blood. 2005 Feb 1;105(3):1303-9. doi: 10.1182/blood-2004-06-2141. Epub 2004 Oct 7. Blood. 2005. PMID: 15471949 Free article.

7

Heparan sulfate proteoglycans and heparanase--partners in osteolytic tumor growth and metastasis.

Sanderson RD, Yang Y, Suva LJ, Kelly T. Sanderson RD, et al. Matrix Biol. 2004 Oct;23(6):341-52. doi: 10.1016/j.matbio.2004.08.004. Matrix Biol. 2004. PMID: 15533755 Review.

8

Identification of an invasion regulatory domain within the core protein of syndecan-1.

Langford JK, Yang Y, Kieber-Emmons T, Sanderson RD. Langford JK, et al. Among authors: sanderson rd. J Biol Chem. 2005 Feb 4;280(5):3467-73. doi: 10.1074/jbc.M412451200. Epub 2004 Nov 24. J Biol Chem. 2005. PMID: 15563454 Free article.

9

Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases.

Kelly T, Suva LJ, Huang Y, Macleod V, Miao HQ, Walker RC, Sanderson RD. Kelly T, et al. Among authors: sanderson rd. Cancer Res. 2005 Jul 1;65(13):5778-84. doi: 10.1158/0008-5472.CAN-05-0749. Cancer Res. 2005. PMID: 15994953

10

Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies.

Sanderson RD, Yang Y, Kelly T, MacLeod V, Dai Y, Theus A. Sanderson RD, et al. J Cell Biochem. 2005 Dec 1;96(5):897-905. doi: 10.1002/jcb.20602. J Cell Biochem. 2005. PMID: 16149080 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters